These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 881095)

  • 1. Comparison of sotalol hydrochloride and methyldopa in essential hypertension.
    Gajendragadkar SV; Clarke WE
    J Int Med Res; 1977; 5(4):233-5. PubMed ID: 881095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two antihypertensive regimens in family practice. Sotalol and methyldopa compared.
    Douglas-Jones AP
    Practitioner; 1978 May; 220(1319):804-8. PubMed ID: 351593
    [No Abstract]   [Full Text] [Related]  

  • 3. Crossover comparison of sotalol plus methyldopa in hypertension.
    Scrazzolo JE; Queirol AG
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):540-6. PubMed ID: 385637
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled clinical investigation of sotalol and alphamethyldopa in hypertensive patients].
    Marinoni C; Lombardi F; Guasconi C; Sportelli G
    Cardiologia; 1984; 29(7-8):405-13. PubMed ID: 6391519
    [No Abstract]   [Full Text] [Related]  

  • 5. beta-Adrenoceptor blockers in the treatment of hypertension.
    Falase AO; Salako LA
    Afr J Med Med Sci; 1979; 8(1-2):13-8. PubMed ID: 45432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of indoramin and methyldopa in hypertension.
    Rosendorff C
    S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotensive action and side effects of clonidine-chlorthalidone and methyldopa-chlorthalidone in treatment of hypertension.
    Amery A; Verstraete M; Bossaert H; Verstreken G
    Br Med J; 1970 Nov; 4(5732):392-5. PubMed ID: 4921284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of debrisoquine and methyldopa in hypertension.
    Pörsti P
    Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antihypertensive effect of guanfacine compared with methyldopa.
    van der Merwe CJ; Kruger SA
    S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy.
    Horvath JS; Phippard A; Korda A; Henderson-Smart DJ; Child A; Tiller DJ
    Obstet Gynecol; 1985 Nov; 66(5):634-8. PubMed ID: 3903581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
    Muiesan G; Agabiti-Rosei E; Alicandri C; Motolese M
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():35-41. PubMed ID: 354827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of nisoldipine and alpha-methyldopa in aged patients with isolated systolic hypertension].
    Guillén Llera F; Reuss JM; Sagués F; Tobares N
    Rev Clin Esp; 1991 Dec; 189(9):412-5. PubMed ID: 1792369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study.
    Glazer N
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):249-56. PubMed ID: 805019
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.